Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Recurrent Still’s Disease

Irvind Buttar*, Elizabeth McCuaig, Harry Fischer, Erin Patton

Internal Medicine, Northwell Health/Lenox Hill Hospital, New York, United States

Abstract: Adult-onset Still’s disease (AOSD) is a systemic inflammatory disorder. Its clinical presentation is similar to the systemic form of Juvenile idiopathic arthritis (JIA). In this case report we explore a young female 22 years after a diagnosis of JIA and 4 years after her diagnosis of AOSD who presents with systemic inflammatory symptoms. Some of the symptoms consistent with her previous diagnosis and some new. Specifically the new symptom of her diffuse lymphadenopathy lead to a differential of possible lymphoproliferative disease. After a biopsy and multiple admissions with unrelenting symptoms the patient was diagnosed with a flare of AOSD. We explore her case in depth with the question in mind: Does one diagnosed with JIA remain on long term therapy to avoid recurrent flares and progression to AOSD, and if so for how long?

Keywords: stills disease, juvenile idiopathic arthritis, lymphadenopathy

Received September 14, 2022; Revised October 17, 2022; Accepted October 28, 2022

Citation: Irvind Buttar, Elizabeth McCuaig, Harry Fischer, Erin Patton, Recurrent Still’s Disease. American Journal of Medical Case Reports, 10 (10). 274-276. January 2022. doi:10.12691/ajmcr-10-10-6

1. Introduction

Adult-onset Still’s disease (AOSD) and Juvenile Idiopathic Arthritis have been associated together for over twenty years. Whether or not the two are the same continuation of one disease has yet to be determined [1]. There are theories that they are one disease with a change in phenotype over years and other theories that they are separate diseases with overlapping symptoms [2,3]. In this case report we describe a case of a patient with both diseases diagnosed.

The following criteria have been established to help diagnose AOSD [4]:

Table 1. DIAGNOSTIC CRITERIA FOR AOSD

Using the above criteria, a total of 5 features must be present and 2 of those being major diagnostic criteria. Diagnosis requires at least 5 features, with at least 2 of these being major diagnostic criteria. These are important to consider when evaluating patients as many of the symptoms overlap with infectious and oncologic disease. AOSD remains a diagnosis of exclusion, meaning it would be diagnosed after other diseases are ruled out and the above diagnostic criteria is met. Similarly JIA is a diagnosis of exclusion in children with inflammation in one or more joints lasting at least 6 weeks [3].

We report a case of extensive medical evaluation to diagnose a recurrent flare of AOSD in a patient with previously diagnosed JIA.

2. Case Presentation

A 27-year-old Female with a history of AOSD (diagnosed 4 years prior to her hospital admission) and Juvenile Idiopathic Arthritis diagnosed at 22 years prior presented to the hospital with 5 days of fever, chills, cough, congestion, nausea, vomiting, palpitations, chest pain, shortness of breath, headache, diffuse joint pain and a runny nose. This patient had been asymptomatic from an AOSD perspective and off of any medication for 2 years. She had previously taken methotrexate and prednisone in the past, which she self discontinued. Her vitals on presentation were significant for unremitting tachycardia (110s-130s), and fevers up to 102.8 F, normotensive and 99% O2 saturation. On exam she had significant lymphadenopathy throughout and a prominent diffuse scaly rash across her legs and chest. Labs were seen as followed.

Table 2. PATIENTS LABORATORY VALUES WITH UNITS

Blood cultures and urine cultures were negative. Chest/Abdomen/Pelvis CT scan was significant for bilateral hilar lymphadenopathy, bilateral axillary lymphadenopathy and left supraclavicular lymphadenopathy and splenomegaly.

Echocardiogram was within normal limits. Her prior treating rheumatologist reported no prior evidence of lymphadenopathy or eosinophilia. She was started on standing Ibuprofen for symptom control with rheumatology, pulmonology, and hematology consults called for further evaluation of possible bronchoscopy and/or biopsy. Per recommendations of hematology/oncology a left axillary final need aspiration excisional lymph node biopsy was performed by general surgery. The patient was discharged from the hospital and asked to wait for the results of the biopsy before any medication was started. She was discharged with close follow up with outpatient rheumatology. However, prior to her appointment or receiving the results of her biopsy she was readmitted with further progression of tachycardia, fevers and similar symptoms 1 week after discharge. During that second admission, pathology resulted revealing florid reactive lymphoid hyperplasia with scattered eosinophils and large cells. It was concluded that the patient was not suffering from a malignancy based off of the biopsy and the symptoms stemmed from rheumatologic disease. Per recommendations she was started on prednisone 40 daily inpatient with significant and rapid improvement of symptoms. The patient became hemodynamically stable with resolution of her palpitations rash cough nausea and vomiting and was able to be discharged with close follow up.

At her follow up appointment, she was still on prednisone 40, with improvement of her symptoms overall. She continued to have tachycardia and a minor cough. She followed up with primary care, pulmonology and rheumatology. The patient expressed that she felt overall better since her discharge but felt some side effects of the prednisone and was eager to be tapered off of it. She felt anxious which was one of the main symptoms that caused her to self discontinue her prednisone in the past. After a full set of labs outpatient, she was started on methotrexate (MTX) 10 mg weekly, recalling that this was the therapy that helped her best in prior years. This patient saw much improvement after starting MTX and was able to be slowly tapered from her prednisone weeks later.

3. Discussion

Our patient presented with 4/4 major criteria of AOSD as mentioned in our introduction and ¾ minor criteria. As her evaluation involved biopsies and culturing, it can be said that it was a diagnosis of exclusion. However, it prompts considering if someone was previously diagnosed with AOSD/JIA and has remission of disease – do they need full evaluation ruling out other presentations to diagnose their flare up. This requires understanding the trajectory of JIA, and AOSD.

Multiple studies have been done using long term follow up to understand the trajectory and length of JIA. There are multiple hypothesis, one study showed 19-44% of patients with monocyclic courses with no relapses, 10-41% of patients with unpredictable exacerbations after months-years, 35-57% of patients with chronic progressive course [5]. It appears our patient has unpredictable exacerbations however, since she had worsening symptoms, it is possible she has a chronic progressive course. While biologic treatment response is the mainstay way of categorizing, it would take some years to fully understand what her disease fits under. Packham reports patients continued to have symptoms for a range of 13-27 years following initial diagnosis [4]. Sampalis states Still’s disease has a duration of approximately 10 years, with 50% of patients requiring treatment after those ten years [6].

This patient specifically had relapsing and remitting effects for at least up to 22 years when considering both diagnosis she had. With the initial diagnosis of JIA patients should have continuous close follow up [7]. She was lost to follow up as her disease had remitted. The time period a patient with this disease would need to be on long term therapy to prevent recurrent disease, and whether Still’s disease is the adult form of JIA is unknown due to the variety of presentation [8,9]. Perhaps patients with this diagnosis need much longer therapy than 2-3 years to prevent subsequent remission. The two diseases are associated due to similar presentations, and gene expression analysis [10]. Multiple studies have been done analyzing the similar patterns between the two diseases specifically. Inoue found that patients with both diseases had a common cytokine profile pattern and increase in IL-6 and IL18 specifically [11]. The similarity, and maybe even continuity helps the argument that the one disease is just the continuation of the other. When the two cytokine profiles were compared, it gave insight on which clinical symptoms patients suffered from more severely. While further analysis and studying is needed, this can help management and correlation of the two diseases, as certain studies have done by testing disease response to the same therapy [12].

4. Conclusions

While half of patients with a diagnosis of juvenile idiopathic arthritis have progression into adult hood, it is important to have consistent follow up throughout adulthood and heavily consider systemic symptoms as a flare of disease as seen in Packham's studies. Whether or not JIA always manifests to Still’s or other diseases has not been established to date. Had our patient had better follow up and monitoring of her disease, perhaps the flare up would not have been so severe requiring hospitalization and lymph node biopsy. The American College of Rheumatology has created a set of documentation and questionnaires to help transition care from pediatric to adult care which our patient would have greatly benefited from the implementation of.

References

[1]   | M. Yamaguchi, A. Ohta, T. Tsunematsu et al., “Preliminary criteria for classification of adult Still's disease,” Journal of Rheumatology, vol. 19, no. 3, pp. 424-430, 1992.
[2]   | Silva JR, Brito I: “Systemic juvenile idiopathic arthritis versus adult-onset Still´s disease: the pertinence of changing the current classification criteria.” Acta Reumatol Port. 2020, 45:150-151.

[3]  
Mitrovic S, Hassold N, Kamissoko A, Rosine N, Mathian A, Mercy G, Pertuiset E, Nocturne G, Fautrel B, Koné-Paut I. Adult-onset Still's disease or systemic-onset juvenile idiopathic arthritis and spondyloarthritis: overlapping syndrome or phenotype shift? Rheumatology (Oxford). 2022 May 30; 61(6): 2535-2547.

[4]   | Tomaras S, Goetzke CC, Kallinich T, Feist E: “Adult-Onset Still’s Disease: Clinical Aspects and Therapeutic Approach.” J Clin Med. 2021, 12:733.
[5]   | Packham JC, Hall MA: “Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional 3 of 4 outcome.” Rheumatology, Volume. 2002:1428-1435.
[6]   | Sampias JS, Esdaile JM, Medsger jr TA, et al.: “A controlled study of the long-term prognosis of adult still's disease”. American Journal of Medicine. 1995, 98.
[7]   | Hersh, A., von Scheven, E., & Yelin, E. (2011: “Adult outcomes of childhood-onset rheumatic diseases”. Nature reviews. Rheumatology. 7: 290-295.
[8]   | Efthimiou P, Georgy S: “Pathogenesis and management of adult-onset Still's disease”. Semin Arthritis Rheum. 2006, 36: 144-52.
[9]   | Jacques M. G. W. Wouters, Levinus B. A. van de Putte: “Adult-onset Still's Disease”; Clinical and Laboratory Features, Treatment and Progress of 45 Case. QJM: An International Journal of Medicine. 1986, 21: 1055-1065.
[10]   | Ju-Yang Jung, Ji-Won Kim, Chang-Hee Suh and Hyoun-Ah Kim: “Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease”. Frontiers. 2020.
[11]   | Natsumi Inoue, Masaki Shimizu, Shinichiro Tsunoda, Mitsuhiro Kawano, Masami Matsumura, Akihiro Yachie: “Cytokine profile in adult-onset Still's disease. Comparison with systemic juvenile idiopathic arthritis”, Clinical Immunology,Volume. 169: 8-13.
[12]   | Nirmala, N., Brachat, A., Feist, E: “Gene-expression analysis of adult-onset Still’s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity.” Pediatr Rheumatol 13.